A substrate analog inhibitor of renin that is effective in vivo

https://doi.org/10.1016/S0006-291X(80)80158-6Get rights and content

Summary

A potent inhibitor of primate renin effective in vivo has been synthesized. The peptide, Pro-His-Pro-Phe-His-Phe-Phe-Val-Tyr-Lys, is an analog of the amino acid sequence found between residues 6 and 13 of renin natural substrate (angiotensinogen). The inhibitor is eight times more soluble at physiologic pH and is cleared from circulation about two-orders of magnitude more slowly than earlier substrate analog inhibitors which were not active in vivo. Infusion of the inhibitor into the monkey (M. fascicularis) blocks the rise in mean arterial pressure caused by exogenous human renin, but not by angiotensin I or II. When injected into a salt-depleted monkey, the peptide lowers blood pressure in a dose-dependent manner about as effectively as the converting enzyme inhibitor, teprotide.

References (12)

  • MiyazakiM et al.

    Japan. J. Pharmacol.

    (1978)
  • HancockWS et al.

    Anal. Biochem.

    (1978)
  • PalsDT et al.

    Circ. Res.

    (1971)
  • CushmanDW et al.

    Biochemistry

    (1977)
  • MenardJ et al.
  • SkeggsLT et al.

    J. Exp. Med.

    (1968)
There are more references available in the full text version of this article.

Cited by (43)

  • Chapter 1 Aspartyl proteinases

    1987, New Comprehensive Biochemistry
  • Angiotensin II generated by a human renal carboxypeptidase

    1986, Biochemical and Biophysical Research Communications
  • Evolution of diverse classes of renin inhibitors through the years

    2011, Aspartic Acid Proteases as Therapeutic Targets
View all citing articles on Scopus
View full text